GPER1 and microRNA: Two Players in Breast Cancer Progression
- PMID: 33374170
- PMCID: PMC7795792
- DOI: 10.3390/ijms22010098
GPER1 and microRNA: Two Players in Breast Cancer Progression
Abstract
Breast cancer is the main cause of morbidity and mortality in women worldwide. However, the molecular pathogenesis of breast cancer remains poorly defined due to its heterogeneity. Several studies have reported that G Protein-Coupled Estrogen Receptor 1 (GPER1) plays a crucial role in breast cancer progression, by binding to estrogens or synthetic agonists, like G-1, thus modulating genes involved in diverse biological events, such as cell proliferation, migration, apoptosis, and metastasis. In addition, it has been established that the dysregulation of short sequences of non-coding RNA, named microRNAs (miRNAs), is involved in various pathophysiological conditions, including breast cancer. Recent evidence has indicated that estrogens may regulate miRNA expression and therefore modulate the levels of their target genes, not only through the classical estrogen receptors (ERs), but also activating GPER1 signalling, hence suggesting an alternative molecular pathway involved in breast tumor progression. Here, the current knowledge about GPER1 and miRNA action in breast cancer is recapitulated, reporting recent evidence on the liaison of these two players in triggering breast tumorogenic effects. Elucidating the role of GPER1 and miRNAs in breast cancer might provide new tools for innovative approaches in anti-cancer therapy.
Keywords: CAFs; GPER1; breast cancer; estrogens; miRNAs; microRNAs.
Conflict of interest statement
The author declares no conflict of interest.
Figures
References
-
- Globocan Estimated Cancer Incidence, Mortality et Prevalence Worldwide in 2018. [(accessed on 23 December 2020)];2018 Available online: http://globocan.iarc.fr/Default.aspx.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
